U.S., Dec. 17 -- An application to own the trademark for 'AXIMRIS XR' has been filed on Jun. 23, 2025.
Owner(s):
Zurich Pharma INC; Unit # 100, 23155 NORTHWESTERN HWY, , MICHIGAN
Goods and/or Services:
For: Drug delivery systems comprising controlled timed-release and/or targeted-release pharmaceutical formulations, provided as integral components of pharmaceutical preparations; pharmaceutical preparations incorporating such drug delivery systems in the form of oral solid dosage units, namely tablets and capsules; all for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric and gastrointestinal tract disorders, hypertension, infection, inflammation, pain, rheumato...